Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias
To investigate the potential efficacy of panaxadiol saponins component (PDS-C), a biologically active fraction isolated from total ginsenosides, to reverse chemotherapy-induced myelosuppression and pancytopenia caused by cyclophamide (CTX).
Mice with myelosuppression induced by CTX were treated with PDS-C at a low- (20 mg/kg), moderate- (40 mg/kg), or high-dose (80 mg/kg) for 7 consecutive days. The level of peripheral white blood cell (WBC), neutrophil (NEU) and platelet (PLT) were measured, the histopathology and colony formation were observed, the protein kinase and transcription factors in hematopoietic cells were determined by immunohistochemical staining and Western blot.
In response to PDS-C therapy, the peripheral WBC, NEU and PLT counts of CTX-induced myelosuppressed mice were significantly increased in a dose-dependent manner. Similarly, bone marrow histopathology examination showed reversal of CTX-induced myelosuppression with increase in overall bone marrow cellularity and the number of hematopoietic cells (P<0.01). PDS-C also promoted proliferation of granulocytic and megakaryocyte progenitor cells in CTX-treated mice, as evidenced by significantly increase in colony formation units-granulocytes/monocytes and -megakaryocytes (P<0.01). The enhancement of hematopoiesis by PDS-C appears to be mediated by an intracellular signaling pathway, this was evidenced by the up-regulation of phosphorylated mitogen-activated protein kinase (p-MEK) and extracellular signal-regulated kinases (p-ERK), and receptor tyrosine kinase (C-kit) and globin transcription factor 1 (GATA-1) in hematopoietic cells of CTX-treated mice (P<0.05).
PDS-C possesses hematopoietic growth factor-like activities that promote proliferation and also possibly differentiation of hematopoietic progenitor cells in myelosuppressed mice, probably mediated by a mechanism involving MEK and ERK protein kinases, and C-kit and GATA-1 transcription factors. PDS-C may potentially be a novel treatment of myelosuppression and pancytopenia caused by chemotherapy.
Keywordspanaxadiol saponins component ginsenosides chemotherapy-induced myelosuppression mitogen-activated protein kinase extracellular signal-regulated kinase receptor tyrosine kinase globin transcription factor 1 Chinese medicine
Unable to display preview. Download preview PDF.
- 8.Gao RL, Xu CL, Jin JM. Effect of total saponins of Panax ginseng on hematopoietic progenitor cells in normal human and aplastic anemia patients. Chin J Integr Tradit West Med (Chin) 1992;12:285–287,261-282.Google Scholar
- 9.Chen XH, Gao RL, Xu WH. Effect of ginsenosides in inducing proliferation and transcription factor of erythrocytic, granulo-monocytic and megakarocytic cell lines. Chin J Integr Tradit West Med (Chin) 2001;21:40–42.Google Scholar
- 11.Jin J, Tao H, Gao R. Effect of ginsenosides on proliferation and differentiation of human CD34+ hematopoietic stem/progenitor cells. Chin J Integr Tradit West Med (Chin) 2000;20:673–676.Google Scholar
- 14.Fang GL, Gao RL, Lin XJ, Jin JM. Effects of Ginseng panaxadiol saponin on proliferation and differentiation of human bone marrow CD34+ cells. J Exp Hematol (Chin) 2007;15:776–779.Google Scholar
- 20.Gao RL, Xu WH, Lin XJ, Chen XH, Wu CQ. Up-regulation of transcription factors GATA-1 and GATA-2 induced by Panax notoginosides in hematopoietic cells. Chin J Hematol (Chin) 2004;25:281–284.Google Scholar